Navigation Links
VistaGen, WARF sign license agreement for human embryonic stem cell technology
Date:12/18/2008

MADISON, VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.

VistaGen, a biotechnology company based in South San Francisco, is one of the world's leading companies focused on using the power of stem cell technology to transform the ways drugs are discovered and tested. WARF is the private, non-profit patenting and licensing organization for the University of Wisconsin-Madison, one of the top-ranked public research universities in the U.S.

The licensed patents result from the research of stem cell pioneer James Thompson of the University of Wisconsin Stem Cell and Regenerative Medicine Center and director of regenerative biology at the new Morgridge Institute for Research. The license will accelerate VistaGen's commercial programs focused on providing customized, next-generation, stem cell-based predictive toxicology and drug discovery screening assays to increase preclinical research and development (R&D) productivity for the pharmaceutical industry.

"This agreement with WARF is another critical step in our strategy to become a 'one-stop-shop' for the world's premier stem cell differentiation systems," says Ralph Snodgrass, VistaGen's CEO. "It enhances our fundamental expertise for capturing the value of human embryonic stem cell biology for predictive toxicology, drug discovery screening and drug development. When combined with our strong stem cell-based intellectual property estate, the key terms of the new license provide a strong foundation to support our commercial programs focused on high-end R&D services, strategic discovery collaborations and enabling licenses."

"We are very pleased to have signed a licensing agreement with VistaGen," says Andy DeTienne, WARF's licensing manager for stem cell technologies. "VistaGen's approach to the commercialization of hum
'/>"/>

Contact: Janet L. Kelly
jkelly@warf.org
608-890-1491
University of Wisconsin-Madison
Source:Eurekalert

Page: 1 2

Related biology news :

1. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Syntermed licenses Emory ERTb software for enhanced cardiac imaging
4. Iowa Corn Promotion Board, NJIT to license breakthrough, safe bio-plastic alternative
5. FSU, Magnet Lab researchers license critical petroleum data
6. Pfizer inks global license to Genomatix Software and databases
7. Integrated Fuel Technologies gets worldwide license for Argonne-developed Diesel DeNOx Catalyst
8. New high fiber barley licensed to grow
9. Springer and the Physiological Society of Japan sign publishing agreement
10. Saving Sumatra: Indonesia reaches historic agreement
11. Zebra Technologies Enters Into Revolving Credit Agreement to Support Company Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ... beliefs about the condition and the best ways to treat ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Information with Figures (pdf download) , ... law postulated by Ernst Abbe in 1873 for ... and his co-workers have established a new law ... applications range from the imaging of cell interiors ...
... arrival of the first humans in ancient Australia may ... University of Colorado, Australian National University, and Bates College.* ... researchers traced evidence of diet and the environment contained ... 140,000 years to reconstruct what happened. The remains showed ...
... A team of researchers led by the University of ... becomes permanently etched in the brain - a discovery ... anxiety and post-traumatic stress. , U of T physiology ... of Seoul National University in South Korea, and ...
Cached Biology News:New law for resolution allows unprecedented sharpness in fluorescence microscopy 2New law for resolution allows unprecedented sharpness in fluorescence microscopy 3Did humans cause ecosystem collapse in ancient Australia? 2Study charts origins of fear 2
(Date:12/19/2014)... Lawrence, MA (PRWEB) December 19, 2014 ... flow MRLAFMQ test for the Detection of Aflatoxin M1 ... test to receive independent third party validation. The peer ... Science Unit of the Institute for Agricultural and Fisheries ... Francis Group. , Aflatoxin B1, the most toxic ...
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., a ... drugs for diseases of the central nervous system, today ... chief executive officer, will present at the 33 rd ... will take place at 3:00 p.m. PST on Tuesday, ... San Francisco, Calif. ...
(Date:12/19/2014)... REDWOOD CITY, Calif. , Dec. 19, 2014 ... , USA) announced today that they have been ... Technologies 1,2 is a privately held company that ... processing of next generation sequencing (NGS) data for the ... into the Roche Sequencing Unit, and will continue to ...
(Date:12/19/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/fhh9rj/technology ) ... Innovations in Smart Fabrics (Technical Insights)" report ... http://photos.prnewswire.com/prnh/20130307/600769 The Research Service titled ... assessment on technological advancements and market for Smart ... 1. The Smart Fabrics market is expected to ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Innovations in Smart Fabrics (Technical Insights) 2
... 15, 2011 Kevin W. Sharer, chairman and chief executive ... has announced his plan to retire from the Company at ... Amgen.  To facilitate an orderly transition process, Sharer will step ... chairman of the Company,s Board of Directors until December 31, ...
... Realty Trust, Inc. (NYSE: BMR ) today announced ... 2011 dividend of $0.20 per share of common stock.  The ... common share. BioMed also announced that its ... share of the company,s 7.375% Series A Cumulative Redeemable Preferred Stock ...
... 15, 2011   Ecology Coatings, Inc. (OTCQB: ECOC), ... announced that it has developed bio-based GRAS (generally recognized ... are GRAS, they can be used to make coatings ... placed in direct contact with food and food packaging. ...
Cached Biology Technology:Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012 2Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012 3BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends 2Ecology Coatings Develops Coatings Safe for Direct Contact with Food Products 2
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Biology Products: